APDN241220C2500
- 0.00
- 0.000.00%
Applied DNA Sciences Newsroom
WHO Extends Mpox Emergency; Canada Reports First Clade I Case
Express News | World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
APDN Files for Resale of 41.6 Million Shares by Selling Stockholders
Applied DNA Sciences Files to Sell 41.64M Shares of Common Stock for Holders
Express News | Applied DNA Sciences Inc: On Nov 12, Received Notice That Co Is Not in Compliance With Nasdaq's Minimum Bid Price Requirements
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast
S&P 500 Edges Lower; US Crude Oil Inventories Fall
Alphabet +5%, Posts Upbeat Results
12 Health Care Stocks Moving In Wednesday's Intraday Session
First Mpox Case Linked to African Outbreak Reported in U.K.
Why Applied DNA Sciences (APDN) Stock Is Down 37% Today
Express News | Applied DNA Sciences - Pricing of $6.5 Mln Registered Direct Offering and Concurrent Private Placement
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
Reported Earlier, 'New Mpox Variant Detected In Germany: Health Authority' - The Economic Times
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
WHO Approves First Mpox Diagnostic Test for Emergency Use
Express News | Amh Equity LLC Reports 9.71% Passive Stake in Applied DNA Sciences Inc as of Oct 1 - SEC Filing
12 Health Care Stocks Moving In Monday's Intraday Session
'Mpox Cases Double In Los Angeles County, Health Officials Urge Vaccination; Los Angeles County Public Health Officials Report Increase, Recommend Prevention Measures' - Pasadena Now
Express News | Biden On Sudan Says End This War Now; Let's Move Quickly To Face Mpox Outbreak In Africa